• Username (E-mail)
  • Password
Dow 19,827 0.5%  EStoxx50 3,299 0.3%  Nikkei 19,138 0.3%  EUR 1.0702 0.4% 
Nasdaq 5,555 0.3%  FTSE100 7,198 -0.1%  Yen 114.6250 0.0%  Oil 55.5 2.4% 
S&P500 2,271 0.3%  DAX 11,630 0.3%  GBP 1.2380 0.4%  Gold 1,214 -0.5% 

Vertex Pharmaceuticals share [Symbol: VRTX / ISIN: US92532F1003]

Estimates* for Vertex Pharmaceuticals Inc. in USD

  2015 2016 2017 2018 2019 2020
Revenue 1,032.33 1,695.45 2,088.00 2,711.84 3,364.66 3,971.87
Dividend 0.00 0.00 0.00 0.00
Dividend Yield (in %) % % % % % %
EPS -1.11 0.80 1.88 3.54 4.99 6.10
P/E Ratio -114.94 98.50 42.03 22.34 15.84 12.94
EBIT -468.66 -19.08 302.19 808.47 1,347.50 1,665.46
EBITDA -402.00 14.05 378.47 752.98 1,040.83 1,431.57
Net Profit -268.34 195.76 486.39 996.04 1,446.08 1,884.85
Net Profit Adjusted -268.34 195.76 486.39 996.04 1,446.08 1,884.85
Pre-Tax Profit -559.58 -93.01 281.03 746.20 1,256.59 1,747.40
Net Profit (Adjusted)
EPS (Clean) -1.11 0.80 1.88 3.54 4.99 6.10
EPS (Reported) -2.31 -0.56 0.90 2.75 3.93 4.82
Gross Income 914.08 1,492.90 1,906.38 2,593.61 3,238.29 3,810.33
Cash Flow from Investing 268.95 -18.71 29.28 -42.30 -43.16 -46.19
Cash Flow from Operations -346.00 187.35 481.15 884.18 1,537.83 1,913.55
Cash Flow from Financing 160.00 20.58 -86.92 37.00 79.60 84.95
Cash Flow per Share -1.35 0.63 0.89 1.60
Free Cash Flow -501.00 120.24 323.18 578.79 1,471.83 1,844.25
Free Cash Flow per Share -1.64 0.44 0.24 1.41
Book Value per Share 2.86 4.32 5.69 8.70 19.57 26.82
Net Debt -643.15 -722.74 -1,285.07 -1,628.21
Research & Development Exp. 996.17 1,076.44 1,149.51 1,230.70 1,308.30 1,277.45
Capital Expenditure 51.20 57.21 74.00 53.50 66.00 69.30
Selling, General & Admin. Exp. 377.08 430.76 461.44 514.27 553.95 571.01
Shareholder’s Equity 1,116.50 1,242.23 1,850.78 2,254.46 4,898.58 6,728.95
Total Assets 2,466.45 2,785.07 3,221.96 3,659.11 5,946.58 7,729.51
* Average Estimates in Million (e.g. Revenue) or per share (e.g. Dividend). Source: FactSet